Davita - Hopkinsville Dialysis is a medicare approved dialysis facility center in Hopkinsville, Kentucky and it has 17 dialysis stations. It is located in Christian county at 1914 South Virginia Street, Hopkinsville, KY, 42240. You can reach out to the office of Davita - Hopkinsville Dialysis at (270) 885-7750. This dialysis clinic is managed and/or owned by Davita. Davita - Hopkinsville Dialysis has the following ownership type - Profit. It was first certified by medicare in September, 1976. The medicare id for this facility is 182519 and it accepts patients under medicare ESRD program.
| Name | Davita - Hopkinsville Dialysis |
|---|---|
| Location | 1914 South Virginia Street, Hopkinsville, Kentucky |
| No. of Dialysis Stations | 17 |
| Medicare ID | 182519 |
| Managed By | Davita |
| Ownership Type | Profit |
| Late Shifts | No |
| 1914 South Virginia Street, Hopkinsville, Kentucky, 42240 | |
| (270) 885-7750 | |
News Archive
Officials running the federal health insurance website hope to resolve glitches before open enrollment begins Nov. 15, but warn consumers not to expect a seamless experience. Meanwhile, the unusually low enrollment in Obamacare plans in Iowa and South Dakota stemmed from one insurer's business decisions.
A nationwide, government-sponsored study finds that people with a common form of diabetic retinopathy can benefit from a medication first developed to combat another potentially blinding disease, age-related macular degeneration (AMD). Treating diabetic macular edema (DME) with ranibizumab (Lucentis) eye injections, plus laser treatment if needed, appears to result in better vision than laser treatment alone, according to the Diabetic Retinopathy Clinical Research (DRCR) Network study published today in Ophthalmology online, the journal of the American Academy of Ophthalmology (Academy). DME is the main cause of vision loss in people with diabetes mellitus.
Patients admitted with COVID-19 at select hospitals may now volunteer to enroll in a clinical trial to test the safety and efficacy of a potential new treatment for the disease.
Excessive noise, hearing loss, vascular constriction, old age - hearing difficulties can be caused by many factors. To help improve the quality of life of people with hearing impairment, Mannheim start-up Vibrosonic have developed a new, innovative hearing aid with an integrated loudspeaker that sits directly on the eardrum.
› Verified 3 days ago
| NPI Number | 1417910522 |
| Organization Name | Hopkinsville Dialysis |
| Doing Business As | Dva Renal Healthcare Inc |
| Address | 115 N Virginia St Hopkinsville, Kentucky, 42240 |
| Phone Number | (270) 887-5622 |
News Archive
Officials running the federal health insurance website hope to resolve glitches before open enrollment begins Nov. 15, but warn consumers not to expect a seamless experience. Meanwhile, the unusually low enrollment in Obamacare plans in Iowa and South Dakota stemmed from one insurer's business decisions.
A nationwide, government-sponsored study finds that people with a common form of diabetic retinopathy can benefit from a medication first developed to combat another potentially blinding disease, age-related macular degeneration (AMD). Treating diabetic macular edema (DME) with ranibizumab (Lucentis) eye injections, plus laser treatment if needed, appears to result in better vision than laser treatment alone, according to the Diabetic Retinopathy Clinical Research (DRCR) Network study published today in Ophthalmology online, the journal of the American Academy of Ophthalmology (Academy). DME is the main cause of vision loss in people with diabetes mellitus.
Patients admitted with COVID-19 at select hospitals may now volunteer to enroll in a clinical trial to test the safety and efficacy of a potential new treatment for the disease.
Excessive noise, hearing loss, vascular constriction, old age - hearing difficulties can be caused by many factors. To help improve the quality of life of people with hearing impairment, Mannheim start-up Vibrosonic have developed a new, innovative hearing aid with an integrated loudspeaker that sits directly on the eardrum.
› Verified 3 days ago
| Experience Measure | Provider | National Avg. |
|---|---|---|
| Patients who reported that nephrologists always communicated and cared for them. | 61% | 67% |
| Patients who reported that nephrologists usually communicated and cared for them. | 15% | 15% |
| Patients who reported that nephrologists sometimes or never communicated and cared for them. | 24% | 18% |
| Patients who gave their nephrologists a rating of 9 or 10 on a scale of 0 (worst possible) to 10 (best possible). | 52% | 60% |
| Patients who gave their nephrologists a rating of 7 or 8 on a scale of 0 (worst possible) to 10 (best possible). | 23% | 26% |
| Patients who gave their nephrologists a rating of 6 or less than 6 on a scale of 0 (worst possible) to 10 (best possible). | 25% | 14% |
News Archive
Officials running the federal health insurance website hope to resolve glitches before open enrollment begins Nov. 15, but warn consumers not to expect a seamless experience. Meanwhile, the unusually low enrollment in Obamacare plans in Iowa and South Dakota stemmed from one insurer's business decisions.
A nationwide, government-sponsored study finds that people with a common form of diabetic retinopathy can benefit from a medication first developed to combat another potentially blinding disease, age-related macular degeneration (AMD). Treating diabetic macular edema (DME) with ranibizumab (Lucentis) eye injections, plus laser treatment if needed, appears to result in better vision than laser treatment alone, according to the Diabetic Retinopathy Clinical Research (DRCR) Network study published today in Ophthalmology online, the journal of the American Academy of Ophthalmology (Academy). DME is the main cause of vision loss in people with diabetes mellitus.
Patients admitted with COVID-19 at select hospitals may now volunteer to enroll in a clinical trial to test the safety and efficacy of a potential new treatment for the disease.
Excessive noise, hearing loss, vascular constriction, old age - hearing difficulties can be caused by many factors. To help improve the quality of life of people with hearing impairment, Mannheim start-up Vibrosonic have developed a new, innovative hearing aid with an integrated loudspeaker that sits directly on the eardrum.
› Verified 3 days ago
| Experience Measure | Provider | National Avg. |
|---|---|---|
| Patients who reported that dialysis center staff always communicated well, kept patients comfortable and pain-free as possible. | 61% | 62% |
| Patients who reported that dialysis center staff usually communicated, kept patients comfortable and pain-free as possible. | 16% | 20% |
| Patients who reported that dialysis center staff sometimes or never communicated, kept patients comfortable and pain-free. | 23% | 18% |
| Patients who gave their dialysis facility staff a rating of 9 or 10 on a scale of 0 (worst possible) to 10 (best possible). | 59% | 62% |
| Patients who gave their dialysis facility staff a rating of 7 or 8 on a scale of 0 (worst possible) to 10 (best possible). | 33% | 26% |
| Patients who gave their dialysis facility staff a rating of 6 or less than 6 on a scale of 0 (worst possible) to 10 (best possible). | 8% | 12% |
News Archive
Officials running the federal health insurance website hope to resolve glitches before open enrollment begins Nov. 15, but warn consumers not to expect a seamless experience. Meanwhile, the unusually low enrollment in Obamacare plans in Iowa and South Dakota stemmed from one insurer's business decisions.
A nationwide, government-sponsored study finds that people with a common form of diabetic retinopathy can benefit from a medication first developed to combat another potentially blinding disease, age-related macular degeneration (AMD). Treating diabetic macular edema (DME) with ranibizumab (Lucentis) eye injections, plus laser treatment if needed, appears to result in better vision than laser treatment alone, according to the Diabetic Retinopathy Clinical Research (DRCR) Network study published today in Ophthalmology online, the journal of the American Academy of Ophthalmology (Academy). DME is the main cause of vision loss in people with diabetes mellitus.
Patients admitted with COVID-19 at select hospitals may now volunteer to enroll in a clinical trial to test the safety and efficacy of a potential new treatment for the disease.
Excessive noise, hearing loss, vascular constriction, old age - hearing difficulties can be caused by many factors. To help improve the quality of life of people with hearing impairment, Mannheim start-up Vibrosonic have developed a new, innovative hearing aid with an integrated loudspeaker that sits directly on the eardrum.
› Verified 3 days ago
| Experience Measure | Provider | National Avg. |
|---|---|---|
| Patients who reported that 'YES', their nephrologists and dialysis center staff provided them the information they needed to take care of them. | 86% | 80% |
| Patients who reported that 'NO', their nephrologists and dialysis center staff does not provided them the information they needed to take care of them. | 14% | 20% |
| Patients who gave their dialysis center a rating of 9 or 10 on a scale of 0 (worst possible) to 10 (best possible). | 62% | 68% |
| Patients who gave their dialysis center a rating of 7 or 8 on a scale of 0 (worst possible) to 10 (best possible). | 23% | 20% |
| Patients who gave their dialysis center a rating of 6 or less than 6 on a scale of 0 (worst possible) to 10 (best possible). | 15% | 12% |
News Archive
Officials running the federal health insurance website hope to resolve glitches before open enrollment begins Nov. 15, but warn consumers not to expect a seamless experience. Meanwhile, the unusually low enrollment in Obamacare plans in Iowa and South Dakota stemmed from one insurer's business decisions.
A nationwide, government-sponsored study finds that people with a common form of diabetic retinopathy can benefit from a medication first developed to combat another potentially blinding disease, age-related macular degeneration (AMD). Treating diabetic macular edema (DME) with ranibizumab (Lucentis) eye injections, plus laser treatment if needed, appears to result in better vision than laser treatment alone, according to the Diabetic Retinopathy Clinical Research (DRCR) Network study published today in Ophthalmology online, the journal of the American Academy of Ophthalmology (Academy). DME is the main cause of vision loss in people with diabetes mellitus.
Patients admitted with COVID-19 at select hospitals may now volunteer to enroll in a clinical trial to test the safety and efficacy of a potential new treatment for the disease.
Excessive noise, hearing loss, vascular constriction, old age - hearing difficulties can be caused by many factors. To help improve the quality of life of people with hearing impairment, Mannheim start-up Vibrosonic have developed a new, innovative hearing aid with an integrated loudspeaker that sits directly on the eardrum.
› Verified 3 days ago
| Dialysis patients with Hemoglobin data | 40 |
| Medicare patients who had average hemoglobin (hgb) less than 10 g/dL | 15 |
News Archive
Officials running the federal health insurance website hope to resolve glitches before open enrollment begins Nov. 15, but warn consumers not to expect a seamless experience. Meanwhile, the unusually low enrollment in Obamacare plans in Iowa and South Dakota stemmed from one insurer's business decisions.
A nationwide, government-sponsored study finds that people with a common form of diabetic retinopathy can benefit from a medication first developed to combat another potentially blinding disease, age-related macular degeneration (AMD). Treating diabetic macular edema (DME) with ranibizumab (Lucentis) eye injections, plus laser treatment if needed, appears to result in better vision than laser treatment alone, according to the Diabetic Retinopathy Clinical Research (DRCR) Network study published today in Ophthalmology online, the journal of the American Academy of Ophthalmology (Academy). DME is the main cause of vision loss in people with diabetes mellitus.
Patients admitted with COVID-19 at select hospitals may now volunteer to enroll in a clinical trial to test the safety and efficacy of a potential new treatment for the disease.
Excessive noise, hearing loss, vascular constriction, old age - hearing difficulties can be caused by many factors. To help improve the quality of life of people with hearing impairment, Mannheim start-up Vibrosonic have developed a new, innovative hearing aid with an integrated loudspeaker that sits directly on the eardrum.
› Verified 3 days ago
Adult patinets who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be atleast 1.7, that means they are receiving right amount of dialysis. Pediatric patients who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be 1.8.
Higher percentages should be better.
| Adult patients getting regular hemodialysis at the center | 64 |
| Adult patient months included in Kt/V greater than or equal to 1.2 | 620 |
| Percentage of adult patients getting regular hemodialysis at the center | 97 |
| Percentage of pediatric patients getting regular hemodialysis at the center |
News Archive
Officials running the federal health insurance website hope to resolve glitches before open enrollment begins Nov. 15, but warn consumers not to expect a seamless experience. Meanwhile, the unusually low enrollment in Obamacare plans in Iowa and South Dakota stemmed from one insurer's business decisions.
A nationwide, government-sponsored study finds that people with a common form of diabetic retinopathy can benefit from a medication first developed to combat another potentially blinding disease, age-related macular degeneration (AMD). Treating diabetic macular edema (DME) with ranibizumab (Lucentis) eye injections, plus laser treatment if needed, appears to result in better vision than laser treatment alone, according to the Diabetic Retinopathy Clinical Research (DRCR) Network study published today in Ophthalmology online, the journal of the American Academy of Ophthalmology (Academy). DME is the main cause of vision loss in people with diabetes mellitus.
Patients admitted with COVID-19 at select hospitals may now volunteer to enroll in a clinical trial to test the safety and efficacy of a potential new treatment for the disease.
Excessive noise, hearing loss, vascular constriction, old age - hearing difficulties can be caused by many factors. To help improve the quality of life of people with hearing impairment, Mannheim start-up Vibrosonic have developed a new, innovative hearing aid with an integrated loudspeaker that sits directly on the eardrum.
› Verified 3 days ago
| Adult patients getting regular peritoneal dialysis at the center | 12 |
| Adult patient months included in Kt/V greater than or equal to 1.7 | 115 |
| Percentage of adult patients getting regular peritoneal dialysis at the center | 97 |
| Percentage of pediatric patients getting regular peritoneal dialysis at the center |
News Archive
Officials running the federal health insurance website hope to resolve glitches before open enrollment begins Nov. 15, but warn consumers not to expect a seamless experience. Meanwhile, the unusually low enrollment in Obamacare plans in Iowa and South Dakota stemmed from one insurer's business decisions.
A nationwide, government-sponsored study finds that people with a common form of diabetic retinopathy can benefit from a medication first developed to combat another potentially blinding disease, age-related macular degeneration (AMD). Treating diabetic macular edema (DME) with ranibizumab (Lucentis) eye injections, plus laser treatment if needed, appears to result in better vision than laser treatment alone, according to the Diabetic Retinopathy Clinical Research (DRCR) Network study published today in Ophthalmology online, the journal of the American Academy of Ophthalmology (Academy). DME is the main cause of vision loss in people with diabetes mellitus.
Patients admitted with COVID-19 at select hospitals may now volunteer to enroll in a clinical trial to test the safety and efficacy of a potential new treatment for the disease.
Excessive noise, hearing loss, vascular constriction, old age - hearing difficulties can be caused by many factors. To help improve the quality of life of people with hearing impairment, Mannheim start-up Vibrosonic have developed a new, innovative hearing aid with an integrated loudspeaker that sits directly on the eardrum.
› Verified 3 days ago
An important goal of dialysis is to maintain normal levels of various minerals in the body, such as calcium. This shows the percentage of patients treated at Davita - Hopkinsville Dialysis with elevated calcium levels.
| Patients with hypercalcemia | 76 |
| Hypercalcemia patient months | 768 |
| Hypercalcemia patients with serumcalcium greater than 10.2 mg | 1 |
| Patients with Serumphosphor | 75 |
| Patients with Serumphosphor less than 3.5 mg/dL | 10 |
| Patients with Serumphosphor from 3.5 to 4.5 mg/dL | 29 |
| Patients with Serumphosphor from 4.6 to 5.5 mg/dL | 28 |
| Patients with Serumphosphor from 5.6 to 7 mg/dL | 21 |
| Patients with Serumphosphor greater than 7 mg/dL | 12 |
News Archive
Officials running the federal health insurance website hope to resolve glitches before open enrollment begins Nov. 15, but warn consumers not to expect a seamless experience. Meanwhile, the unusually low enrollment in Obamacare plans in Iowa and South Dakota stemmed from one insurer's business decisions.
A nationwide, government-sponsored study finds that people with a common form of diabetic retinopathy can benefit from a medication first developed to combat another potentially blinding disease, age-related macular degeneration (AMD). Treating diabetic macular edema (DME) with ranibizumab (Lucentis) eye injections, plus laser treatment if needed, appears to result in better vision than laser treatment alone, according to the Diabetic Retinopathy Clinical Research (DRCR) Network study published today in Ophthalmology online, the journal of the American Academy of Ophthalmology (Academy). DME is the main cause of vision loss in people with diabetes mellitus.
Patients admitted with COVID-19 at select hospitals may now volunteer to enroll in a clinical trial to test the safety and efficacy of a potential new treatment for the disease.
Excessive noise, hearing loss, vascular constriction, old age - hearing difficulties can be caused by many factors. To help improve the quality of life of people with hearing impairment, Mannheim start-up Vibrosonic have developed a new, innovative hearing aid with an integrated loudspeaker that sits directly on the eardrum.
› Verified 3 days ago
The arteriovenous (AV) fistulae is considered long term vascular access for hemodialysis because it allows good blood flow, lasts a long time, and is less likely to get infected or cause blood clots than other types of access. Patients who don't have time to get a permanent vascular access before they start hemodialysis treatments may need to use a venous catheter as a temporary access.
| Patients included in arterial venous fistula and catheter summaries | 52 |
| Patient months included in arterial venous fistula and catheter summaries | 458 |
| Percentage of patients getting regular hemodialysis at the center that used an arteriovenous (AV) fistulae for their treatment | 58 |
| Percentage of patients receiving treatment through Vascular Catheter for 90 days/longer | 7 |
News Archive
Officials running the federal health insurance website hope to resolve glitches before open enrollment begins Nov. 15, but warn consumers not to expect a seamless experience. Meanwhile, the unusually low enrollment in Obamacare plans in Iowa and South Dakota stemmed from one insurer's business decisions.
A nationwide, government-sponsored study finds that people with a common form of diabetic retinopathy can benefit from a medication first developed to combat another potentially blinding disease, age-related macular degeneration (AMD). Treating diabetic macular edema (DME) with ranibizumab (Lucentis) eye injections, plus laser treatment if needed, appears to result in better vision than laser treatment alone, according to the Diabetic Retinopathy Clinical Research (DRCR) Network study published today in Ophthalmology online, the journal of the American Academy of Ophthalmology (Academy). DME is the main cause of vision loss in people with diabetes mellitus.
Patients admitted with COVID-19 at select hospitals may now volunteer to enroll in a clinical trial to test the safety and efficacy of a potential new treatment for the disease.
Excessive noise, hearing loss, vascular constriction, old age - hearing difficulties can be caused by many factors. To help improve the quality of life of people with hearing impairment, Mannheim start-up Vibrosonic have developed a new, innovative hearing aid with an integrated loudspeaker that sits directly on the eardrum.
› Verified 3 days ago
The rate of hospitalization show you whether patients who were being treated regularly at a certain dialysis center were admitted to the hospital more often (worse than expected), less often (better than expected), or about the same (as expected), compared to similar patients treated at other centers.
| Standard Hospitalization Summary Ratio(SHR) Year | January, 2016 - December, 2016 |
| Patients in facility's Hospitalization Summary | 70 |
| Hospitalization Rate in facility | 146.7 (As Expected) |
| Hospitalization Rate: Upper Confidence Limit | 269.2 |
| Hospitalization Rate: Lower Confidence Limit | 82.6 |
News Archive
Officials running the federal health insurance website hope to resolve glitches before open enrollment begins Nov. 15, but warn consumers not to expect a seamless experience. Meanwhile, the unusually low enrollment in Obamacare plans in Iowa and South Dakota stemmed from one insurer's business decisions.
A nationwide, government-sponsored study finds that people with a common form of diabetic retinopathy can benefit from a medication first developed to combat another potentially blinding disease, age-related macular degeneration (AMD). Treating diabetic macular edema (DME) with ranibizumab (Lucentis) eye injections, plus laser treatment if needed, appears to result in better vision than laser treatment alone, according to the Diabetic Retinopathy Clinical Research (DRCR) Network study published today in Ophthalmology online, the journal of the American Academy of Ophthalmology (Academy). DME is the main cause of vision loss in people with diabetes mellitus.
Patients admitted with COVID-19 at select hospitals may now volunteer to enroll in a clinical trial to test the safety and efficacy of a potential new treatment for the disease.
Excessive noise, hearing loss, vascular constriction, old age - hearing difficulties can be caused by many factors. To help improve the quality of life of people with hearing impairment, Mannheim start-up Vibrosonic have developed a new, innovative hearing aid with an integrated loudspeaker that sits directly on the eardrum.
› Verified 3 days ago
The rate of readmission show you whether patients who were being treated regularly at Davita - Hopkinsville Dialysis were readmitted more often (worse than expected), less often (better than expected), or about the same (as expected), compared to similar patients treated at other dialysis centers.
| Standard Readmission Summary Ratio(SRR) Year | January, 2016 - December, 2016 |
| Readmission Rate in facility | 10.3 (Better than Expected) |
| Readmission Rate: Upper Confidence Limit | 20.9 |
| Readmission Rate: Lower Confidence Limit | 4 |
News Archive
Officials running the federal health insurance website hope to resolve glitches before open enrollment begins Nov. 15, but warn consumers not to expect a seamless experience. Meanwhile, the unusually low enrollment in Obamacare plans in Iowa and South Dakota stemmed from one insurer's business decisions.
A nationwide, government-sponsored study finds that people with a common form of diabetic retinopathy can benefit from a medication first developed to combat another potentially blinding disease, age-related macular degeneration (AMD). Treating diabetic macular edema (DME) with ranibizumab (Lucentis) eye injections, plus laser treatment if needed, appears to result in better vision than laser treatment alone, according to the Diabetic Retinopathy Clinical Research (DRCR) Network study published today in Ophthalmology online, the journal of the American Academy of Ophthalmology (Academy). DME is the main cause of vision loss in people with diabetes mellitus.
Patients admitted with COVID-19 at select hospitals may now volunteer to enroll in a clinical trial to test the safety and efficacy of a potential new treatment for the disease.
Excessive noise, hearing loss, vascular constriction, old age - hearing difficulties can be caused by many factors. To help improve the quality of life of people with hearing impairment, Mannheim start-up Vibrosonic have developed a new, innovative hearing aid with an integrated loudspeaker that sits directly on the eardrum.
› Verified 3 days ago
Hemodialysis treatment requires direct access to the bloodstream, which can be an opportunity for germs to enter the body and cause infection. This information shows how often patients at Davita - Hopkinsville Dialysis get infections in their blood each year compared to the number of infections expected for the center based on the national average.
| Standard Infection Summary Ratio(SIR) Year | January, 2016 - December, 2016 |
| Infection Rate in facility | 1.37 (As Expected) |
| SIR: Upper Confidence Limit | 3.03 |
| SIR: Lower Confidence Limit | .5 |
News Archive
Officials running the federal health insurance website hope to resolve glitches before open enrollment begins Nov. 15, but warn consumers not to expect a seamless experience. Meanwhile, the unusually low enrollment in Obamacare plans in Iowa and South Dakota stemmed from one insurer's business decisions.
A nationwide, government-sponsored study finds that people with a common form of diabetic retinopathy can benefit from a medication first developed to combat another potentially blinding disease, age-related macular degeneration (AMD). Treating diabetic macular edema (DME) with ranibizumab (Lucentis) eye injections, plus laser treatment if needed, appears to result in better vision than laser treatment alone, according to the Diabetic Retinopathy Clinical Research (DRCR) Network study published today in Ophthalmology online, the journal of the American Academy of Ophthalmology (Academy). DME is the main cause of vision loss in people with diabetes mellitus.
Patients admitted with COVID-19 at select hospitals may now volunteer to enroll in a clinical trial to test the safety and efficacy of a potential new treatment for the disease.
Excessive noise, hearing loss, vascular constriction, old age - hearing difficulties can be caused by many factors. To help improve the quality of life of people with hearing impairment, Mannheim start-up Vibrosonic have developed a new, innovative hearing aid with an integrated loudspeaker that sits directly on the eardrum.
› Verified 3 days ago
Patients with anemia require blood transfusions if their anemia is not managed well by their dialysis center. This information shows whether Davita - Hopkinsville Dialysis's rate of transfusions is better than expected, as expected, or worse than expected, compared to other centers that treat similar patients.
| Standard Transfusion Summary Ratio (STrR) Year | January, 2016 - December, 2016 |
| Patients in facility's Transfusion Summary | 58 |
| Transfusion Rate in facility | 41.9 (As Expected) |
| Transfusion Rate: Upper Confidence Limit | 104.4 |
| Transfusion Rate: Lower Confidence Limit | 18.8 |
News Archive
Officials running the federal health insurance website hope to resolve glitches before open enrollment begins Nov. 15, but warn consumers not to expect a seamless experience. Meanwhile, the unusually low enrollment in Obamacare plans in Iowa and South Dakota stemmed from one insurer's business decisions.
A nationwide, government-sponsored study finds that people with a common form of diabetic retinopathy can benefit from a medication first developed to combat another potentially blinding disease, age-related macular degeneration (AMD). Treating diabetic macular edema (DME) with ranibizumab (Lucentis) eye injections, plus laser treatment if needed, appears to result in better vision than laser treatment alone, according to the Diabetic Retinopathy Clinical Research (DRCR) Network study published today in Ophthalmology online, the journal of the American Academy of Ophthalmology (Academy). DME is the main cause of vision loss in people with diabetes mellitus.
Patients admitted with COVID-19 at select hospitals may now volunteer to enroll in a clinical trial to test the safety and efficacy of a potential new treatment for the disease.
Excessive noise, hearing loss, vascular constriction, old age - hearing difficulties can be caused by many factors. To help improve the quality of life of people with hearing impairment, Mannheim start-up Vibrosonic have developed a new, innovative hearing aid with an integrated loudspeaker that sits directly on the eardrum.
› Verified 3 days ago
The rate of mortality show you whether patients who were being treated regularly at Davita - Hopkinsville Dialysis lived longer than expected (better than expected), don’t live as long as expected (worse than expected), or lived as long as expected (as expected), compared to similar patients treated at other facilities.
| Standard Survival Summary Ratio(SIR) Year | January, 2013 - December, 2016 |
| Patients in facility's Survival Summary | 335 |
| Mortality Rate in facility | 17.3 (As Expected) |
| Mortality Rate: Upper Confidence Limit | 23.6 |
| Mortality Rate: Lower Confidence Limit | 12.4 |
News Archive
Officials running the federal health insurance website hope to resolve glitches before open enrollment begins Nov. 15, but warn consumers not to expect a seamless experience. Meanwhile, the unusually low enrollment in Obamacare plans in Iowa and South Dakota stemmed from one insurer's business decisions.
A nationwide, government-sponsored study finds that people with a common form of diabetic retinopathy can benefit from a medication first developed to combat another potentially blinding disease, age-related macular degeneration (AMD). Treating diabetic macular edema (DME) with ranibizumab (Lucentis) eye injections, plus laser treatment if needed, appears to result in better vision than laser treatment alone, according to the Diabetic Retinopathy Clinical Research (DRCR) Network study published today in Ophthalmology online, the journal of the American Academy of Ophthalmology (Academy). DME is the main cause of vision loss in people with diabetes mellitus.
Patients admitted with COVID-19 at select hospitals may now volunteer to enroll in a clinical trial to test the safety and efficacy of a potential new treatment for the disease.
Excessive noise, hearing loss, vascular constriction, old age - hearing difficulties can be caused by many factors. To help improve the quality of life of people with hearing impairment, Mannheim start-up Vibrosonic have developed a new, innovative hearing aid with an integrated loudspeaker that sits directly on the eardrum.
› Verified 3 days ago
Davita - Hopkinsville Dialysis Location: 1914 South Virginia Street, Hopkinsville, Kentucky, 42240 Phone: (270) 885-7750 |
Davita - Christian County Dialysis Location: 200 Burley Ave, Hopkinsville, Kentucky, 42240 Phone: (270) 707-0701 |
News Archive
Officials running the federal health insurance website hope to resolve glitches before open enrollment begins Nov. 15, but warn consumers not to expect a seamless experience. Meanwhile, the unusually low enrollment in Obamacare plans in Iowa and South Dakota stemmed from one insurer's business decisions.
A nationwide, government-sponsored study finds that people with a common form of diabetic retinopathy can benefit from a medication first developed to combat another potentially blinding disease, age-related macular degeneration (AMD). Treating diabetic macular edema (DME) with ranibizumab (Lucentis) eye injections, plus laser treatment if needed, appears to result in better vision than laser treatment alone, according to the Diabetic Retinopathy Clinical Research (DRCR) Network study published today in Ophthalmology online, the journal of the American Academy of Ophthalmology (Academy). DME is the main cause of vision loss in people with diabetes mellitus.
Patients admitted with COVID-19 at select hospitals may now volunteer to enroll in a clinical trial to test the safety and efficacy of a potential new treatment for the disease.
Excessive noise, hearing loss, vascular constriction, old age - hearing difficulties can be caused by many factors. To help improve the quality of life of people with hearing impairment, Mannheim start-up Vibrosonic have developed a new, innovative hearing aid with an integrated loudspeaker that sits directly on the eardrum.
› Verified 3 days ago